Terapi Tetanus Imunoglobulin pada Pasien Anak dengan Tetanus

Riska Habriel Ruslie; Darmadi Darmadi

doi:10.32502/sm.v2i2.1442

Terapi Tetanus Imunoglobulin pada Pasien Anak dengan Tetanus

Riska Habriel Ruslie, Darmadi Darmadi

Abstract

Walaupun tetanus merupakan penyakit yang dapat dicegah, tetanus masih terjadi akibat defisiensi vaksinasi. Tetanus fatal pada sebagian pasien dan kematian terjadi dalam 2-30 hari. Pengetahuan dan kesadaran petugas kesehatan, terutama departemen gawat darurat perlu disegarkan secara berkesinambungan. Tatalaksana luka, TIG, antibiotik, dan toksoid tetanus sama pentingnya dengan imunisasi primer. Disusun artikel ini yang membahas mengenai terapi tetanus imunoglobulin khususnya pada anak dengan tetanus.

Keywords

tetanus imunoglobulin, Clostridium tetani, tetanus

Full Text:

PDF

References

Pickering LK, Baker CJ, Kimberlin DW, Long SS, editors. Red Book. Report of the Committee on Infectious Diseases. American Academy of Pediatrics. Tetanus (lockjaw). In: 28th ed. Elk Grove Village, IL: American Academy of Pediatrics

Behrman RE, Kliegman RM, Jenson HB, editors. 2004. Nelson Textbook of pediatrics. Aron SS. Tetanus. 17 ed. Philadelphia, Saunders. p.951- 2.

Glickman J, Scott KJ, Canby RC. 1995. Infectious Disease, Phantom notes medicine. 6 th ed. Singapore: Info Acces and Distribution Ltd. p. 53-5.

Menkes JH, Sarnat HB.2000, Textbook of child Neurology. 6th ed. London, Williams & Wilkins.

Weinstein L. Tetanus. In: Feigin RD, Cherry YD, editors.2004. Textbook of Pediatric Infectious Disease. Sth ed. Philadelphia: WB Saunders.p. 1766-75.

Krugman S, Katz SL, Gershon AA, Wilfert CM.2004. Infectious Disease of Children. 11 th ed. St. Louis;Mosbyp. 655-62.

Anonim. Tetanus Immunoglobulin-VF dari. http://www.medsafe.govt.nz/profs/data sheet/t/tettoxtetanusvaccine. pdf. pada tanggal Juli 2012.

CDC.2007. Centers for Disease Control and Prevention. Epidemiology and prevention of vaccine-preventable diseases. 10th ed. Washington DC: Public Health Foundation.

CDC. 2011. Centers for Disease Control and Prevention. Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis (Tdap) vaccine from the Advisory Committee on Immunization Practices MMWR Morb Mortal Wkly Rep. 14;60(1):13-S.

Talecris Biotherapeutics.2010. Tetanus Immune Globulin (Human). New Y ork: Research Triangle Park.

Anonim. Tetanus Immune Globulin dari. www.medscape.com/druginfo/mon ograph?pada Juli 2012

Murphy TV, Slade BA, Broder KR, Kretsinger K, Tiwari T, Joyce PM, et al. 2008. Prevention of pertussis, tetanus, and diphtheria among pregnant and postpartum women and_ their infants recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 57(RR-4):1-51.

Roper MH, Vandelaer JH, Gasse FL. 2007. Maternal and neonatal tetanus. Lancet.370(9603): 1947-59.

Novak RT, Thomas CG.2011. Tetanus. Atlanta: Centers for Disease Control and Prevention

Committee on Infectious Diseases, American Academy of Pediatrics. Red Book: 2006 report of the Committee on Infectious Diseases. 27th ed. Elk Grove Village, IL: American Academy of Pediatrics.p.552-9.

Geeta MG, Krishnakumar P, Mathews L.2007. Intrathecal tetanus immunoglobulins in the management of tetanus. Indian J Pediatr. 74(1):43-5.

CDC. 2006. Centers for Disease Control and Prevention. recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 55(RR- 15):1-48

DOI: https://doi.org/10.32502/sm.v2i2.1442